Apparatus and methods for monitoring and modifying anticoagulation therapy of remotely located patients
First Claim
1. A method of monitoring anticoagulation therapy of a patient, wherein the anticoagulation therapy includes a patient-administered medication regimen selected from the group consisting of warfarin and vitamin K antagonists, heparin and glucosaminoglycans, and direct thrombin inhibitors, and a patient-administered regimen for a coagulation test that monitors efficacy of the medication regimen, wherein the coagulation test is selected from the group consisting of prothrombin time (PT) test, partial thromboplastin time (PTT) test, activated clotting time (ACT) test, heparin assays, ecarin clotting time (ECT) test, and thrombin clotting time test, wherein the apparatus is configured to receive and analyze information regarding patient compliance with the patient-administered medication and coagulation test regimens, and wherein the apparatus is configured to modify the patient-administered medication and coagulation test regimens, the method comprising the following steps performed by a portable apparatus:
- receiving data from a patient at a portable apparatus, wherein the patient data includes at least one of physiological data, pathophysiological data, biological data, psychological data, neuropsychological data, and behavioral data;
assessing severity of the received patient data via the portable apparatus;
prompting the patient to perform a patient-administered coagulation test via the portable apparatus, if the received patient data are assessed to be above a threshold severity level;
receiving coagulation test results from the patient-administered test at the portable apparatus; and
communicating the received coagulation test results of the patient-administered test from the portable apparatus to a healthcare provider via a communications network.
9 Assignments
0 Petitions
Accused Products
Abstract
A patient apparatus is configured to receive and analyze information regarding patient compliance with anticoagulation medication and self-test coagulation regimens related to anticoagulation therapy. In addition, a patient apparatus is configured to receive data from a patient, including physiological data, pathophysiological data, biological data, psychological data, neuropsychological data, and/or behavioral data. Utilizing the received patient data, a patient apparatus can modify a warfarin regimen using an algorithm contained within the apparatus. The apparatus can communicate the modified warfarin regimen to the patient and to third parties, such as remotely located healthcare providers. In addition, the apparatus can prompt a patient when to perform a self-test and can prompt a patient to seek immediate medical attention, or to directly contact medical help, when so warranted.
-
Citations
73 Claims
-
1. A method of monitoring anticoagulation therapy of a patient, wherein the anticoagulation therapy includes a patient-administered medication regimen selected from the group consisting of warfarin and vitamin K antagonists, heparin and glucosaminoglycans, and direct thrombin inhibitors, and a patient-administered regimen for a coagulation test that monitors efficacy of the medication regimen, wherein the coagulation test is selected from the group consisting of prothrombin time (PT) test, partial thromboplastin time (PTT) test, activated clotting time (ACT) test, heparin assays, ecarin clotting time (ECT) test, and thrombin clotting time test, wherein the apparatus is configured to receive and analyze information regarding patient compliance with the patient-administered medication and coagulation test regimens, and wherein the apparatus is configured to modify the patient-administered medication and coagulation test regimens, the method comprising the following steps performed by a portable apparatus:
-
receiving data from a patient at a portable apparatus, wherein the patient data includes at least one of physiological data, pathophysiological data, biological data, psychological data, neuropsychological data, and behavioral data;
assessing severity of the received patient data via the portable apparatus;
prompting the patient to perform a patient-administered coagulation test via the portable apparatus, if the received patient data are assessed to be above a threshold severity level;
receiving coagulation test results from the patient-administered test at the portable apparatus; and
communicating the received coagulation test results of the patient-administered test from the portable apparatus to a healthcare provider via a communications network. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A portable apparatus that monitors anticoagulation therapy of a patient, wherein the anticoagulation therapy includes a patient-administered medication regimen selected from the group consisting of warfarin and vitamin K antagonists, heparin and glucosaminoglycans, and direct thrombin inhibitors, and a patient-administered regimen for a coagulation test that monitors efficacy of the medication regimen, wherein the coagulation test is selected from the group consisting of prothrombin time (PT) test, partial thromboplastin time (PTT) test, activated clotting time (ACT) test, heparin assays, ecarin clotting time (ECT) test, and thrombin clotting time test, comprising:
-
a processor;
a user interface in communication with the processor;
computer code executable by the processor that receives and stores data from a patient, wherein the patient data includes at least one of physiological data, pathophysiological data, biological data, psychological data, neuropsychological data, and behavioral data;
computer code executable by the processor that assesses severity of the received patient data;
computer code executable by the processor that prompts a patient via the user interface to perform a patient-administered coagulation test if the received patient data are assessed to be above a threshold severity level;
computer code executable by the processor that receives and stores coagulation test results from the patient-administered coagulation test;
computer code executable by the processor that communicates the received coagulation test results from the patient-administered coagulation test to a healthcare provider via a communications network. - View Dependent Claims (11, 12, 13, 14, 15, 16, 17, 18)
-
-
19-28. -28. (canceled)
-
29. A method of monitoring disease therapy of a patient via a portable patient apparatus, wherein the disease is selected from the group consisting of asthma, cancer chemotherapy, depression, high blood pressure, seizure disorders, and thrombosis, wherein the disease therapy includes a patient-administered medication regimen and a patient-administered regimen for a test that monitors efficacy of the medication regimen, wherein the portable patient apparatus is configured to receive and analyze information regarding patient compliance with the patient-administered medication and test regimens, and wherein the portable patient apparatus is configured to modify the patient-administered medication and test regimens, the method comprising the following steps performed by the apparatus:
-
receiving data from a patient at a portable patient apparatus, wherein the patient data includes at least one of physiological data, pathophysiological data, biological data, psychological data, neuropsychological data, and behavioral data;
assessing severity of the received patient data via the portable patient apparatus;
prompting the patient to perform a patient-administered test if the received patient data are assessed to be above a threshold severity level via the portable patient apparatus;
receiving test results from the patient-administered test at the portable patient apparatus; and
communicating the received test results of the patient-administered test from the portable patient apparatus to a healthcare provider via a communications network. - View Dependent Claims (30, 31, 32, 33, 34, 35, 36)
-
-
37. A An portable apparatus that monitors disease therapy of a patient, wherein the disease is selected from the group consisting of asthma, cancer chemotherapy, depression, high blood pressure, seizure disorders, and thrombosis, wherein the disease therapy includes a patient-administered medication regimen and a patient-administered regimen for a test that monitors efficacy of the medication regimen, the portable apparatus comprising:
-
a processor;
a user interface in communication with the processor;
computer code executable by the processor that receives and stores data from a patient, wherein the patient data includes at least one of physiological data, pathophysiological data, biological data, psychological data, neuropsychological data, and behavioral data;
computer code executable by the processor that assesses severity of the received patient data;
computer code executable by the processor that prompts the patient via the user interface to perform a patient-administered test if the received patient data are assessed to be above a threshold severity level;
computer code executable by the processor that receives and stores test results from the patient-administered test; and
computer code executable by the processor that communicates the received test results from the patient-administered test to a healthcare provider via a communications network. - View Dependent Claims (38, 39, 40, 41, 42, 43)
-
-
44. A method of monitoring disease therapy of a patient, wherein the disease therapy includes a patient-administered medication regimen and a patient-administered regimen for a test that monitors efficacy of the medication regimen, wherein the test is administered by the patient according to a first schedule, wherein an apparatus is configured to receive and analyze information regarding patient compliance with the patient-administered medication and test regimens, and wherein the apparatus is configured to modify the patient-administered medication and test regimens, the method comprising the following steps performed by the apparatus:
-
receiving test results from a patient-administered test; and
directing the patient to administer future tests according to a second schedule different from the first schedule in response to determining that the received test results are within or not within a desired range, wherein the second schedule has a frequency of administration that is lower in value than a frequency of administration of the first schedule when the received test results are within a desired range, and wherein the second schedule has a frequency of administration that is higher in value than a frequency of administration of the first schedule when the received test results are not within a desired range. - View Dependent Claims (45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55)
-
-
56. A method of monitoring disease therapy of a patient, wherein the disease therapy includes a patient-administered medication regimen and a patient-administered regimen for a test that monitors efficacy of the medication regimen, wherein the patient is required to log on to an apparatus and provide information to the apparatus according to a first log on schedule, the method comprising the following steps performed by the apparatus:
-
receiving information from a patient that indicates that a disease condition of the patient has changed; and
in response to receiving information from the patient that a disease condition has changed, directing the patient to provide future information to the apparatus according to a second log on schedule that is different from the first log on schedule. - View Dependent Claims (57, 58, 59)
-
-
60. An apparatus for monitoring disease therapy of a patient, wherein the disease therapy includes a patient-administered medication regimen and a patient-administered regimen for a test that monitors efficacy of the medication regimen, wherein the test is administered by the patient according to a first schedule, wherein the apparatus comprises:
-
a processor;
computer code executable by the processor that receives and analyzes information regarding patient compliance with the patient-administered medication and test regimens;
computer code executable by the processor that modifies the patient-administered medication and test regimens; and
computer code executable by the processor that directs the patient to administer future tests according to a second schedule different from the first schedule in response to determining that the received test results are within or not within a desired range, wherein the second schedule has a frequency of administration that is lower in value than a frequency of administration of the first schedule when the received test results are within a desired range, and wherein the second schedule has a frequency of administration that is higher in value than a frequency of administration of the first schedule when the received test results are not within a desired range. - View Dependent Claims (61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73)
-
Specification